Abstract
Diabetes is one of the major public health problems and an important modifiable risk factor for cardiovascular diseases. Iran has become increasingly modernized. This factor has led to a higher prevalence obesity, insulin resistance, cardiovascular events, and type 2 diabetes. This was a community base cross-sectional study in a representative sample of urban population (2076 adults aged 18–79 years) from 16 cities in northern Iran. Subjects were interviewed and examined by a trained research team. Blood samples were drawn for biochemical testing. Data analysis was carried out with the SPSS Software, version 14. The prevalence of diabetes was 12.4 % (9.9 % in men, 14.1 % in women, p < 0.002) and increased with age in both sexes. Among diabetic patients, 78.3 % were aware of the diagnosis that 79.7 % received treatment but more than 60 % had not good control. Multiple logistic regression analysis showed that age, family history of diabetes, abdominal obesity, generalized obesity, hypertension, and dyslipidemia were significantly associated with diabetes. In comparison to other studies, the prevalence of diabetes in north of Iran is higher in urban area. These findings indicate that a comprehensive national program for screening and management of this disease is urgently needed to avert the cardiovascular disease epidemic in this area.
Similar content being viewed by others
References
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7.
Motala AA, Omar MA, Pirie FJ. Diabetes in Africa. Epidemiology of type 1 and type 2 diabetes in Africa. J Cardiovasc Risk. 2003;10(2):77.
Engelgau MM, Geiss LS, Saaddine JP, et al. The evolving diabetes burden in the United States. Ann Intern Med. 2004;140(11):945–50.
Dongsheng H, Pengyu F, Xie J, et al. Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study. Diabetes Res Clin Pract. 2008;81(2):250–7.
Bener A, Zirie M, Ibrahim M, et al. Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diabetes Res Clin Pract. 2009;84:99–106.
Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J. 2011;35:303–8.
Basit A, Danish Alvi SF, Fawwad A, et al. Temporal changes in the prevalence of diabetes, impaired fasting glucose and its associated risk factors in the rural area of Baluchistan. Diab Res Clin Pract. 2011. doi:10.1016/j.diabres.2011.08.009.
Anand K, Shah B, Yadav K. Are the urban poor vulnerable to non-communicable diseases? A survey of risk factors for non-communicable diseases in urban slums of Faridabad. Natl Med J India. 2007;20(3):115–20.
Shen J, Goya A, Sperling L. The emerging epidemic of obesity, diabetes, and the metabolic syndrome in China. Cardiol Res Pract. 2012;2012, 178675. 5 pages.
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.
Holt TA, Stables D, Hippisley-Cox J, et al. Identifying undiagnosed diabetes: cross-sectional survey of 3.6 million patients’ electronic records. Br J Gen Pract. 2008;58:192–6.
Tan C, Emmanuel S, Tan B, Jacob E. Prevalence of diabetes and ethnic differences in cardiovascular risk factors—the 1992 Singapore National Health Survey. Diabetes Care. 1999;22:241–7.
Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications-estimates and projections to the year 2010. Diabet Med. 1997;14 Suppl 5:S1–85.
World Health Organization, the prevention of diabetes and its complications, WHO Report, 2006, Available from http://www.who.int/diabetes/prevention flyer/en/ [Accessed on 7/ 8/2008].
Lecomte P, Vol S, Cases E, et al. Impaired fasting glycaemia and undiagnosed diabetes: prevalence, cardiovascular and behavioral risk factors. Diabetes Metab. 2002;28:311–20.
Heine RJ, Mooy JM. Impaired glucose tolerance and unidentified diabetes. Postgrad Med J. 1996;72:67–71.
Rathmann W, Haastert B, Icks A, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia. 2003;46:182–9.
Rguibi M, Belahsen R, et al. Prevalence and associated risk factors of undiagnosed diabetes among adult Moroccan Sahraouian women. Public Health Nutr. 2006;9(6):722–7.
Bando Y, Kanehara H, Aoki K, et al. Characteristics of undiagnosed diabetes mellitus in a population undergoing health screening in Japan: target populations for efficient screening. Diabetes Res Clin Pract. 2009;83(3):341–6.
Bovet P, Hirsiger P, Emery F, et al. Impact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton. Diabetes Metab Syndr Obes. 2011;4:213–23.
Hadaegh F, Bozorgmanesh MR, Ghasemi A, et al. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health. 2008;8:176.
Chang L. Costs are high from undiagnosed diabetes. http://diabetes.webmd.com/news/20090508/costs-are-high-from-undiagnosed-diabetes 11/08/2011.
Delavari A, Mahdavi Hazaveh A, Nourouzi Nezhad A, et al. National program for prevention and control of diabetes in Iran. 2nd ed. Tehran, Iran: Seda publisher; 2004 [In Persian].
Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9(3):237–52.
Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008; 31(Supp 1):S55–60.
Esteghamati A, Gouya MM, Abbasi M, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: national survey of risk factors for non-communicable diseases of Iran. Diabetes Care. 2008;31(1):96–8.
Bahrami H, Sadatsafavi M, Pourshams A, et al. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American Women. BMC Public Health. 2006;6:158.
Haghdoost A-A, Sadeghirad Pharm B, Rezazadehkermani M. Epidemiology and heterogeneity of hypertension in Iran: a systematic review. Arch Iranian Med. 2008;11(4):444–52.
Delavari A, Forouzanfar MH, Alikhani S, et al. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East. Diabetes Care. 2009;32(6):1092–7.
Sharifi F, Mousavinasab SN, Saeini M, et al. Prevalence of metabolic syndrome in an adult urban population of the west of Iran. Exp Diabetes Res. 2009;2009:136501.
Azizi F, Salehi P, Etemadi A, et al. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2003;61(1):29–37.
Azizi F, Azadbakht L, Mirmiran P. Trends in overweight, obesity and central fat accumulation among Tehranian adults between 1998-1999 and 2001-2002: Tehran lipid and glucose study. Ann Nutr Metab. 2005;49(1):3–8.
Saadi H, George CS, Nagelkerke N, et al. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clin Pract. 2007;78:369–77.
Al-Lawati JA, Al Riyami AM, Mohammed AJ, et al. Increasing prevalence of diabetes mellitus in Oman. Diabet Med. 2002;19(11):954–7.
Anjana RM, Pradeepa R, Deepa M, et al. Prevalence of diabetes and prediabetes [impaired fasting glucose and/or impaired glucose tolerance] in urban and rural India: phase I results of the Indian Council of Medical Research–INdia DIABetes [ICMR–INDIAB] study. Diabetologia. 2011;54(12):3022–7.
Gokcel A, Ozsahin AK, Sezgin N, et al. High prevalence of diabetes in Adana, a southern province of Turkey. Diabetes Care. 2003;26(11):3031–4.
Geiss LS, Pan L, Cadwell B, Gregg EW, et al. Changes in incidence of diabetes in U.S. adults, 1997-2003. Am J Prev Med. 2006;30(5):371–7.
Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care. 2002;25(5):829–34.
Golozar A, Khademi H, Kamangar F, et al. Diabetes mellitus and its correlates in an Iranian adult population. PLoS ONE. 2011;6(10):e26725. doi:10.1371/journal.pone.0026725.
Acknowledgments
We gratefully acknowledge the governor of Guilan for the financial support for the study, the Research Vice-Chancellorship of Guilan University for reviewing the project, clinical research development center of Pour-Sina hospital, and especially the health staffs who participated in this study.
Conflict of interest
Authors have no any conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mohtasham-Amiri, Z., Barzigar, A., Kolamroudi, H.R. et al. Prevalence, awareness and control of diabetes in urban area of north of Iran, 2009. Int J Diabetes Dev Ctries 35, 346–350 (2015). https://doi.org/10.1007/s13410-015-0305-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-015-0305-4